Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) EBT Margin (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of EBT Margin data on record, last reported at 32.53% in Q4 2025.

  • For Q4 2025, EBT Margin fell 3159.0% year-over-year to 32.53%; the TTM value through Dec 2025 reached 0.06%, up 21.0%, while the annual FY2025 figure was 0.06%, 21.0% up from the prior year.
  • EBT Margin reached 32.53% in Q4 2025 per TGTX's latest filing, down from 16.02% in the prior quarter.
  • Across five years, EBT Margin topped out at 113643.75% in Q4 2022 and bottomed at 38948.94% in Q3 2022.
  • Average EBT Margin over 5 years is 1926.13%, with a median of 31.62% recorded in 2023.
  • Peak YoY movement for EBT Margin: soared 22771995bps in 2021, then crashed -11367446bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 4051.1% in 2021, then skyrocketed by 2905bps to 113643.75% in 2022, then plummeted by -100bps to 30.71% in 2023, then surged by 97bps to 0.94% in 2024, then plummeted by -3361bps to 32.53% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 32.53% in Q4 2025, 16.02% in Q3 2025, and 21.91% in Q2 2025.